Search Results 431-440 of 10443 for Cholangitis
... cholangitis featured. Featured News. Researchers use artificial intelligence, clinical data to create prediction tool for primary sclerosing cholangitis. Joe ...
rcinoma, Primary sclerosing cholangitis, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Cirrhosis, Acute liver ...
... cholangitis, Acute liver failure, Autoimmune hepatitis, Hemochromatosis ... cholangitis, Liver disease, Alcoholic hepatitis, Hepatopulmonary syndrome.
Primary sclerosing cholangitis (PSC) causes inflammation and scarring of the bile ducts. This rare liver disease is often accompanied by inflammatory bowel ...
... cholangitis, Cholangiocarcinoma, Primary sclerosing cholangitis, Portal hypertension, Liver disease, Alcoholic hepatitis, Hepatopulmonary syndrome, Viral ...
tocellular carcinoma, Cirrhosis, Nonalcoholic fatty liver disease, Primary biliary cholangitis, Cholangiocarcinoma, Primary sclerosing cholangitis, Acute ...
Elafibranor is used in combination with ursodeoxycholic acid (UDCA) to treat primary biliary cholangitis (PBC) in patients who have received UDCA but did ...
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.